OpenLB
Open Library of Bioscience
Advanced Search

Future Medicinal Chemistry

Journal Information
Journal Abbr. Future Med Chem
Web of Sciences Category
Chemistry, Medicinal
Print ISSN 1756-8919
E-ISSN 1756-8927
NLM Catelog ID 101511162
Scopus Source ID 19700174974
Country ENGLAND
Language English
Publisher Future Sci Ltd
Publisher Address United House, 2 Albert Pl, London, England, N3 1qb

Related Publications

Found 2,774 results

Evaluation of novel synthesized thiazole derivatives as potential aromatase inhibitors against breast cancer.
Eman Fayad, Dalal Nasser Binjawhar, Abeer A Ageeli, Dalal Sulaiman Alshaya, Fahmy Gad Elsaid, Amr Yasser Mahmoud, Eman M Radwan, Mohamed Ahmed Elian Sophy, Ahmed Re Mahdy
Future Med Chem. 2024.16(8):707-721 Print-Electronic
Source:PubMed
PMID: 38488019 doi:10.4155/fmc-2023-0323
Leading prodrug strategies for targeted and specific release.
Rupa Bargakshatriya, Sumit Kumar Pramanik
Future Med Chem. Mar 14, 2025.:1-4 Print-Electronic
Source:PubMed
PMID: 40085509 doi:10.1080/17568919.2025.2479412
Protein profiling uncovers IGF-1R inhibition potential of 3-(2-furoyl)-indole scaffolds in hepatocellular carcinoma.
Efficiency Myrsing, H M Chandra Mouli, Pallaprolu Nikhil, Abhishek Sahu, Anupam Jana, P Ramalingam
Future Med Chem. Mar, 2025.17(5):513-528 Print-Electronic
Source:PubMed
PMID: 40028717 doi:10.1080/17568919.2025.2467616
Novel triazoloquinazoline derivatives as VEGFR inhibitors: synthesis, cytotoxic evaluation and studies.
Reda R Mabrouk, Hazem A Mahdy, Abdallah E Abdallah, Ismail Celik, Abdelsalam Mohamed Abdelsalam Ouf, Mariam K Alamoudi, Aisha Alnami, Maged Mohammed Saleh Al Ward, Ahmed B M Mehany, Mohamed Ayman El-Zahabi
Future Med Chem. Mar, 2025.17(5):529-541 Print-Electronic
Source:PubMed
PMID: 39995350 doi:10.1080/17568919.2025.2468146
Synthesis of novel quinoline-thiazolobenzimidazolone hybrids as anticancer agents through caspase-dependent apoptosis.
Houria Bouria, Hayette Alliouche, Mohamed Imed Chouiter, Ali Belfaitah, Teresa Pacheco, Viktor Gala, David Pereira, Artur M S Silva
Future Med Chem. Mar, 2025.17(5):543-555 Print-Electronic
Source:PubMed
PMID: 40008604 doi:10.1080/17568919.2025.2470112
Targeting cyclin-dependent kinase 2 (CDK2) interactions with cyclins and Speedy 1 (Spy1) for cancer and male contraception.
Jeanine Giarolla, Kelsey A Holdaway, Maryam Nazari, Laila Aiad, Bidisha Sarkar, Gunda I Georg
Future Med Chem. Mar, 2025.17(5):607-627 Print-Electronic
Source:PubMed
PMID: 40034037 doi:10.1080/17568919.2025.2463868
Synthesis and in vitro antitrypanosomatid activity of novel 5-nitroindole-rhodanine conjugates.
Emce Badenhorst, Janine Aucamp, Christina Kannigadu, Helena D Janse van Rensburg, Keisuke Suganuma, David D N'Da
Future Med Chem. Mar, 2025.17(5):557-573 Print-Electronic
Source:PubMed
PMID: 39995114 doi:10.1080/17568919.2025.2470110
How does machine learning augment alchemical binding free energy calculations?
Ingo Muegge, Yunhui Ge
Future Med Chem. Mar, 2025.17(5):509-511 Print-Electronic
Source:PubMed
PMID: 39922803 doi:10.1080/17568919.2025.2463870
Refinement of MEK inhibitors.
Ankit Kumar Singh, Adarsh Kumar, Harshwardhan Singh, Amita Verma, Pradeep Kumar
Future Med Chem. Mar, 2025.17(5):501-503 Print-Electronic
Source:PubMed
PMID: 39910918 doi:10.1080/17568919.2025.2463311
Advancements in PROTAC-based therapies for neurodegenerative diseases.
Deyuan Kong, Liying Meng, Pengfei Lin, Guanzhao Wu
Future Med Chem. Mar, 2025.17(5):591-605 Print-Electronic
Source:PubMed
PMID: 39931801 doi:10.1080/17568919.2025.2463310